Horizon Scanning of medium- to long-term burden of Chronic diseases And care Needs to 2030 in Hong Kong (SCAN-2030)
Grant Data
Project Title
Horizon Scanning of medium- to long-term burden of Chronic diseases And care Needs to 2030 in Hong Kong (SCAN-2030)
Principal Investigator
Professor Li, Xue
(Principal Investigator (PI))
Co-Investigator(s)
Dr Chan Sandra Sau Man
(Co-Investigator)
Chen Yingyao
(Co-Investigator)
Dr Siu Wai Kwan Steven
(Co-Investigator)
Professor Chan Esther Wai Yin
(Co-principal investigator)
Professor Leung Wai Keung
(Collaborator)
Professor Lum Terry Yat Sang
(Co-principal investigator)
Dr Luo Hao
(Co-principal investigator)
Professor Na Yung
(Co-principal investigator)
Professor Wong Gloria Hoi Yan
(Co-principal investigator)
Professor Knapp Martin
(Co-Investigator)
Professor Wong Ian Chi Kei
(Collaborator)
Craig Dawn
(Co-Investigator)
Chan Sabrina
(Co-Investigator)
Duration
36
Start Date
2023-06-30
Amount
4214286
Conference Title
Horizon Scanning of medium- to long-term burden of Chronic diseases And care Needs to 2030 in Hong Kong (SCAN-2030)
Keywords
Health technology assessment, Real-world data and evidence, Disease burden and care needs, Cost-effectiveness evaluation, Non-communicable diseases
Discipline
Others - Medicine, Dentistry and HealthDisease Model Development
HKU Project Code
R7007-22
Grant Type
Research Impact Fund (RIF) 2022/23
Funding Year
2022
Status
On-going
Objectives
(1) To assess the current disease burden, medication utilisation pattern, unmet needs in the use of innovative medicines, using territory-wide electronic medical records (real-world data) (Work Package 1).(2) To project the population-specific 10-year disease burden and care needs among Hong Kong population, using real-world data-based disease simulation modelling (Work Package 2).(3) To evaluate the cost-effectiveness, return-on-investment, and budget impact of introducing innovative medicine versus standard care, using global and local-evidence-based decision-analytic modelling (Work Package 3).(4) To establish a living pipeline of global innovative treatments and their prioritisation criterion for chronic disease management that will allow the dynamic identification of local unmet needs and preparedness of the healthcare system (overall objective).